Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s10072-023-07167-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Vascular-Dependent and -Independent Actions of Calcitonin Gene-Related Peptide in Cardiovascular Disease
- (2022) Fulye Argunhan et al. Frontiers in Physiology
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
- (2022) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability
- (2022) George S. Stergiou et al. JOURNAL OF HYPERTENSION
- Bariatric Surgery in Migraine patients: CGRP Level and Weight Loss
- (2022) Helia Hemasian Etefagh et al. OBESITY SURGERY
- Blood Pressure in Migraine Patients Treated With Monoclonal Anti-CGRP (receptor) Antibodies: A Prospective Follow-up Study
- (2022) Simone de Vries Lentsch et al. NEUROLOGY
- Association between migraine and cardiovascular disease: A cross-sectional study
- (2022) Kai Wang et al. Frontiers in Cardiovascular Medicine
- Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
- (2021) David W. Dodick et al. HEADACHE
- The effects of CGRP in vascular tissue - classical vasodilation and multiple shadowed effects
- (2020) Iben Sohn et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women
- (2020) Tobias Kurth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic novelties in migraine: new drugs, new hope?
- (2019) Thien Phu Do et al. JOURNAL OF HEADACHE AND PAIN
- CSD-induced arterial dilatation and plasma protein extravasation are unaffected by fremanezumab: implications for CGRP's role in migraine with aura
- (2019) Aaron J. Schain et al. JOURNAL OF NEUROSCIENCE
- Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
- (2019) Islam Y. Elgendy et al. Journal of the American Heart Association
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
- (2014) C M Booth et al. BRITISH JOURNAL OF CANCER
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
- (2010) Lars Edvinsson et al. CEPHALALGIA
- Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
- (2010) K. Y. Chan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Migraine and cardiovascular disease: Possible mechanisms of interaction
- (2009) M. E. Bigal et al. NEUROLOGY
- Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
- (2007) L Edvinsson et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search